| Melanoma: The Negative Impact |
|
Melanoma is a cancer that appears to start mostly in the skin. The skin has two main layers: the epidermis and the dermis. Deep in the epidermis are cells called melanocytes. Melanocytes make melanin, which gives color to the skin. When skin is exposed to the sun, the melanocytes make more melanin and cause the skin to tan or darken. Sometimes melanocytes cluster together and form moles, called nevi. Moles are common and are usually not cancerous. There are three types of skin cancer: basal cell carcinoma starts in the basal cells; squamous cell carcinoma starts in the squamous cells; and melanoma starts in the melanocytes. Melanoma is less common than basal and squamous cell carcinomas. It can start in other places in the body where melanocytes are found, such as the eyes, the mouth or under the fingernails, although these types of melanoma are rare. A melanoma diagnosis can bring about short- and long-term psychological distress. Skin care professionals who can provide an atmosphere of relaxation and understanding, and have the knowledge of how to handle a client who has undergone treatment for melanoma, can make a hugely positive difference. Another task that needs to be taken on by skin care professionals is raising the awareness of melanoma in order to save many lives. Public awareness of the danger of sun burns also needs to increase. Skin professionals must encourage people to look for the early stages of skin cancer and to seek medical help. If caught in the early stages, melanoma can be totally cured; however, if it is left unnoticed for too long, it becomes one of the most lethal forms of cancer. It will kill. Melanoma Treatment Methods People with melanoma may opt to treat it through surgery, chemotherapy, radiation therapy, biological therapy or they may undergo a combination of treatments. At any stage of the disease, people with melanoma may have treatment to control pain and other symptoms of the cancer, to relieve the side effects of therapy, and to ease emotional and practical problems. This kind of treatment is called symptom management, supportive care or palliative care. Surgery. Surgery is the usual treatment for melanoma—the surgeon removes the tumor and some normal tissue around it. This procedure reduces the chance that cancer cells will be left in the area. The width and depth of the surrounding skin that needs to be removed depends on the thickness of the melanoma and how deeply it has invaded the skin. If a large area of tissue is removed, the surgeon may do a skin graft. For this procedure, the doctor uses skin from another part of the body to replace the skin that was removed. Lymph nodes near the tumor may be removed as well because cancer can spread through the lymphatic system. If the pathologist finds cancer cells in the lymph nodes, it may mean that the disease has also spread to other parts of the body. Two procedures are used to remove the lymph nodes. Sentinel lymph node biopsy. A sentinel lymph node biopsy is done after the biopsy of the melanoma but before the wider excision of the tumor. If a sentinel node contains cancer cells, the surgeon removes the rest of the lymph nodes in the area. However, if a sentinel node does not contain cancer cells, no additional lymph nodes are removed. Dissection. A lymph node dissection is when all the lymph nodes in the area of the melanoma are removed. Skin side effects of surgery. Scarring can be a problem for some clients. Generally, scars fade with time, and how noticeable the scar is depends on where the melanoma was, how well the person heals and whether the person develops raised scars, known as keloids. Skin grafts can reduce the scarring caused by the removal of a large growth; however, scars will still be noticeable. Scar tissue is usually weaker, less elastic, more prone to re-injury and can be much more sensitive to pain than normal, healthy tissue. Specialized massage techniques for tissue adhesion can be performed. Surgery to remove lymph nodes from the underarm or groin area may damage the lymphatic system and slow the flow of lymphatic fluid in the arm or leg. Lymphatic fluid may build up in a limb and cause swelling, or lymphedema. Adjustments need to be made when giving skin care treatments to redirect away from areas of removed lymph nodes and to reduce pressure. Chemotherapy. Chemotherapy, the use of drugs to kill cancer cells, is sometimes used to treat melanoma. People with melanoma may receive chemotherapy via mouth or injection. Either way, the drugs enter the bloodstream and travel throughout the body. Through the use of isolated limb perfusion on an arm or leg, chemotherapy drugs are put directly into the bloodstream of that limb. The flow of blood to and from the limb is stopped for a short period of time, allowing most of the drug to reach the tumor directly. Most of the chemotherapy remains in that limb. Skin side effects of chemotherapy. The side effects of chemotherapy depend mainly on the specific drugs and the dose. In general, anticancer drugs affect cells that divide rapidly, especially the cells of the blood, such as red blood cells, white blood cells and platelets. When white blood cells are very low, a client is more prone to infections, and if the platelets are low, a client is more prone to bruising or bleeding more easily. EducationAs with sun exposure, recent studies indicate a relationship between the use of tanning beds and malignant melanoma, as well as nonmelanoma skin cancers, such as squamous and basal cell carcinomas. Thus, the consequences of regular tanning bed use may include disfigurement from the removal of skin cancers and early death if the cancer is a malignant melanoma, as well as substantial costs for screening, treating and monitoring skin cancer patients. Young adults should be discouraged from using indoor tanning equipment and restricted access to tanning beds by minors should be strongly considered. PreventionWith the incidence of melanoma still rising, it is clear that primary prevention efforts have not yet taken hold. The only approach firmly rooted in evidence is to minimize sun exposure. The use of sun-protective clothing appears to be the next best strategy. There is conflicting data regarding the protective effect of suncreens for melanoma, although there is no controversy regarding their ability to prevent basal and squamous cell carcinoma. Protection against UVA has been a long-standing feature of widely available suncreens, whereas UVB protection has more recently been engineered into all mainstream products. It is possible that the increased widespread use of these broad-spectrum sunscreens will provide more meaningful protective effects throughout the coming decades. A new option is becoming available for early melanoma detection in the ability to test for the mutation of the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene. This mutation has been linked to a very high risk of melanoma and was recently the focus of a study reported in the May 2011 issue of Genetics in Medicine. All people with a family history of melanoma showed a reduction in anxiety and depression after getting tested. Patients in this study had a strong family history of melanoma, with at least three relatives affected by the disease. These same patients who tested positive for the high-risk gene became more likely to use sunscreen and to undergo regular skin examinations by a physician for early melanoma detection. Article written by: Morag Currin |
